ネズミにおけるクロピドグレル-フェルル酸コンジュガートの薬理動力学とシステム前生物変換
Rong Shen1, Huan Yang1, Yu Song2
1Research Center for Drug Metabolism, School of Life Science, Jilin University, Changchun, China.
Journal of pharmaceutical sciences
|September 2, 2025
まとめ
クロピドグレルの新しい派生物であるDclop- FAは,薬剤の投与を強化し,生物変換を改善することにより,その変異性を減少させます. この新しいアプローチは,クロピドグレル耐性を克服し,患者の治療結果を改善するための有望な戦略です.
科学分野:
- 薬理学について
- 薬物の代謝
- 薬剤化学
背景:
- クロピドグレル (Clop) は低生物変換効率と高個体間変動性を示し,治療効果を制限する.
- 既存のクロピドグレル製剤は,一貫した薬物投与と患者の反応に問題があります.
研究 の 目的:
- バイオトランスフォーメーションの効率を改善し,個体間の変動性を減らすために,新しいデュテラートクロピドグレル-フェルル酸誘導体 (Dclop-FA) を開発する.
- Dclop- FAの薬動性と代謝のプロフィールを臨床前モデルで調査する.
主な方法:
- 特定のデュテレーションとエステル製薬剤の修正による新しいDclop-FA誘導体の合成.
- Dclop- FAの経口投与後のラットでの薬動学的研究
- 生物変異経路を明らかにするために,カヌル化されたラットを用いて代謝プロファイリング.
- 酵素運動分析とエステラーゼスクリーニングで,キーヒドロラーゼ (CES2,AADAC) を特定する.
主要な成果:
- クロピドグレルとフェル酸の併用と比較して,Dclop- FAは活性代謝物の全身露出を6. 0倍増加させた.
- Dclop- FAの完全な変換は,肝臓の代謝を回避して,腸内吸収中に発生しました.
- カーボキシルエステラーゼ2 (CES2) とアリラセタミド脱酸化酵素 (AADAC) は,Dclop- FAの水解を媒介する主要な酵素として特定された.
- 修飾はC7-メチルエステルの水解を減少させ,クロピドグレルの変動の主要な源であるCYP依存のチオフェンの酸化を回避した.
結論:
- Dclop- FAは,活性代謝物の生物変異と全身露出を著しく強化している.
- デュテレーションと代謝バイパス戦略は,クロピドグレルの反応の変動性を効果的に減少させる.
- クロピドグレル耐性を克服するための有望な治療候補である.
さらに関連する動画
関連する概念動画
Drug Biotransformation: Overview
2.9K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.9K
Factors Influencing Drug Absorption: Presystemic Elimination
340
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
340
Drug Metabolism: Phase II Reactions
4.1K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.1K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
293
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
293
First Pass Effect
6.4K
Presystemic elimination, or the first-pass effect, is the metabolism of drugs that reduces their effective concentration at the site of action. Apart from the first-pass effect, the systemic bioavailability of the drug is also reduced by other factors, including incomplete absorption or chemical degradation of drugs.
Depending on the route of administration, drugs can be metabolized in the liver, intestine, lungs, and vasculature. Orally administered drugs are first absorbed through the...
Depending on the route of administration, drugs can be metabolized in the liver, intestine, lungs, and vasculature. Orally administered drugs are first absorbed through the...
6.4K
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
406
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
406


